Overview

HALAVEN (Eribulin) is a chemotherapy medication used to treat certain types of breast cancer. It is administered via injection and works by inhibiting cancer cell growth and division.

Benefits

• Effective in treating metastatic breast cancer.
• Works by disrupting the cancer cell cycle.
• Can be used in patients who have previously received chemotherapy.

Dosage

The recommended dosage of HALAVEN is typically 1.4 mg/m² administered as an intravenous infusion on days 1 and 8 of a 21-day treatment cycle. Always follow your healthcare provider's instructions regarding dosage and administration.

Side Effects

Common side effects may include:

• Fatigue
• Nausea and vomiting
• Hair loss
• Constipation
• Low blood cell counts

Consult your healthcare provider if you experience severe side effects or have concerns during treatment.

FAQs

What is HALAVEN used for?

HALAVEN is primarily used to treat patients with metastatic breast cancer.

How is HALAVEN administered?

HALAVEN is given as an intravenous infusion by a healthcare professional.

What should I do if I miss a dose?

If you miss a dose, contact your healthcare provider for guidance on how to proceed.

Can HALAVEN be used in combination with other treatments?

HALAVEN may be used in combination with other cancer treatments, but this should be discussed with your healthcare provider.